Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec): Bone marrow histopathology and correlation with genetic status

John L. Frater, Martin S. Tallman, Daina Variakojis, Brian J. Druker, Debra Resta, Mary Beth Riley, Mary Ann Hrisinko, Lo Ann C. Peterson

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec): Bone marrow histopathology and correlation with genetic status'. Together they form a unique fingerprint.

Medicine & Life Sciences